Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer

Clinical trial NCT00086827 · COMPLETED

Trial details

NCT number: NCT00086827
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Small Cell Lung Cancer

Start date: 2004-05-01
Primary completion: 2006-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.